American Bio Medica Corporation (ABMC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
American Bio Medica Revenue
American Bio Medica had revenue of $164.00K in the quarter ending March 31, 2023, a decrease of -53.28%. This brings the company's revenue in the last twelve months to $726.00K, down -63.75% year-over-year. In the year 2022, American Bio Medica had annual revenue of $913.00K, down -58.84%.
Revenue (ttm)
726.00K
Revenue Growth
-63.75%
P/S Ratio
0.00
Revenue / Employee
36.30K
Employees
20
Market Cap
48.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 913.00K | -1.31M | -58.84% |
| Dec 31, 2021 | 2.22M | -1.93M | -46.52% |
| Dec 31, 2020 | 4.15M | 492.00K | 13.46% |
| Dec 31, 2019 | 3.66M | -217.00K | -5.60% |
| Dec 31, 2018 | 3.87M | -1.04M | -21.20% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
American Bio Medica News
- 3 years ago - ABMC Reports Third Quarter 2021 Results - Accesswire
- 3 years ago - ABMC Reports Second Quarter 2021 Results - Accesswire
- 3 years ago - ABMC Reports First Quarter 2021 Results - Accesswire